Education
About Us
Working with TipRanks
Follow Us
Alaunos Therapeutics Inc (TCRT)
:TCRT
TCRT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.31 - $6.20
Previous CloseN/A
Volume6.23K
Average Volume (3M)243.09K
Market Cap
$5.29M
Enterprise Value$3.47M
Total Cash (Recent Filing)$2.88M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-1.45
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.92
Shares Outstanding2,205,716
10 Day Avg. Volume37,219
30 Day Avg. Volume243,092
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue578.84
Enterprise Value/Gross Profit347.30
Enterprise Value/Ebitda-0.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Alaunos Therapeutics News
TCRT FAQ
What was Alaunos Therapeutics Inc’s price range in the past 12 months?
Alaunos Therapeutics Inc lowest stock price was $1.31 and its highest was $6.20 in the past 12 months.
What is Alaunos Therapeutics Inc’s market cap?
Alaunos Therapeutics Inc’s market cap is $5.29M.
When is Alaunos Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alaunos Therapeutics Inc’s earnings last quarter?
Alaunos Therapeutics Inc released its earnings results on Aug 08, 2024. The company reported -$0.705 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.705.
Is Alaunos Therapeutics Inc overvalued?
According to Wall Street analysts Alaunos Therapeutics Inc’s price is currently Overvalued.
Does Alaunos Therapeutics Inc pay dividends?
Alaunos Therapeutics Inc does not currently pay dividends.
What is Alaunos Therapeutics Inc’s EPS estimate?
Alaunos Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alaunos Therapeutics Inc have?
Alaunos Therapeutics Inc has 2,205,716 shares outstanding.
What happened to Alaunos Therapeutics Inc’s price movement after its last earnings report?
Alaunos Therapeutics Inc reported an EPS of -$0.705 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.481%.
Which hedge fund is a major shareholder of Alaunos Therapeutics Inc?
Currently, no hedge funds are holding shares in TCRT
Company Description
Alaunos Therapeutics Inc
Alaunos Therapeutics (TCRT) is a biotechnology company focused on the development and commercialization of innovative, cell-based cancer immunotherapies. Operating within the healthcare and biotechnology sectors, the company is committed to advancing its proprietary T-cell receptor (TCR) therapy platform. This platform is designed to harness the power of the body's immune system to target and destroy cancer cells, offering potential treatments for a variety of solid tumor cancers.
Technical Analysis
Theriva Biologics
―
Sonnet BioTherapeutics Holdings
―
Oragenics
―
Windtree Therapeutics
―
Xenetic Biosciences
―
Ownership Overview
14.30% Insiders
2.82% Mutual Funds
<0.01% Other Institutional Investors
82.23% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---